The prevalence of obesity has steadily risen over the past decades, even doubling in more than 70 countries. High levels of body fat (adiposity) and obesity are associated with endocrine and hormonal dysregulation, cardiovascular compromise, hepatic dysfunction, pancreatitis, changes in drug metabolism and clearance, inflammation, and metabolic stress. It is thus unsurprising that obesity can affect the development of and survival from a wide variety of malignancies. This review focuses on acute lymphoblastic leukemia, the most common malignancy in children, to explore the multiple mechanisms connecting acute lymphoblastic leukemia, obesity, and adipocytes, and the implications for leukemia therapy
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) with current cure rates reaching 80% emphas...
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) with current cure rates reaching 80% emphas...
Background: Children who undergo treatment for childhood acute lymphoblastic leukemia (ALL) and lymp...
Acute lymphoblastic leukemia is the most common malignancy in childhood. Continuous progress in risk...
Obesity is responsible for ~90,000 cancer deaths/year, increasing cancer incidence and impairing its...
Obesity affects the prognosis of several types of cancer. However, whether excess body weight is ind...
To determine whether obesity complicated the treatment of childhood acute lymphoblastic leukemia, we...
Obesity is a recognized problem for children treated for acute lymphoblastic leukemia (ALL) and is p...
BACKGROUND: Obesity is a well documented problem associated with childhood acute lymphoblastic leuke...
Background Obesity is a medical problem in survivors of childhood acute lymphoblastic leukemia. Obes...
Objective & Design. We undertook a retrospective review of children diagnosed with acute lymphoblast...
Obesity is associated with poor outcomes in childhood acute lymphoblastic leukaemia (ALL). We explor...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
IntroductionAcute lymphoblastic leukemia (ALL) therapy confers risk for venous thromboembolism (VTE)...
Objectives In this study, it was aimed to determine the prevalence and clinical features of obesity ...
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) with current cure rates reaching 80% emphas...
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) with current cure rates reaching 80% emphas...
Background: Children who undergo treatment for childhood acute lymphoblastic leukemia (ALL) and lymp...
Acute lymphoblastic leukemia is the most common malignancy in childhood. Continuous progress in risk...
Obesity is responsible for ~90,000 cancer deaths/year, increasing cancer incidence and impairing its...
Obesity affects the prognosis of several types of cancer. However, whether excess body weight is ind...
To determine whether obesity complicated the treatment of childhood acute lymphoblastic leukemia, we...
Obesity is a recognized problem for children treated for acute lymphoblastic leukemia (ALL) and is p...
BACKGROUND: Obesity is a well documented problem associated with childhood acute lymphoblastic leuke...
Background Obesity is a medical problem in survivors of childhood acute lymphoblastic leukemia. Obes...
Objective & Design. We undertook a retrospective review of children diagnosed with acute lymphoblast...
Obesity is associated with poor outcomes in childhood acute lymphoblastic leukaemia (ALL). We explor...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
IntroductionAcute lymphoblastic leukemia (ALL) therapy confers risk for venous thromboembolism (VTE)...
Objectives In this study, it was aimed to determine the prevalence and clinical features of obesity ...
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) with current cure rates reaching 80% emphas...
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) with current cure rates reaching 80% emphas...
Background: Children who undergo treatment for childhood acute lymphoblastic leukemia (ALL) and lymp...